iSCORE-PD: an isogenic stem cell collection to research Parkinson Disease
Busquets, O.; Li, H.; Syed, K. M.; Jerez, P. A.; Dunnack, J.; Bu, R. L.; Verma, Y.; Pangilinan, G. R.; Martin, A.; Straub, J.; Du, Y.; Simon, V. M.; Poser, S.; Bush, Z.; Diaz, J.; Sahagun, A.; Gao, J.; Hernandez, D.; Levine, K. S.; Booth, E. O.; Bateup, H.; Rio, D.; Hockemeyer, D.; Blauwendraat, C.; Soldner, F.
Show abstract
Parkinsons disease (PD) is a neurodegenerative disorder caused by complex genetic and environmental factors. Genome-edited human pluripotent stem cells (hPSCs) offer a unique experimental platform to advance our understanding of PD etiology by enabling the generation of disease-relevant cell types carrying patient mutations along with isogenic control cells. To facilitate this approach, we generated a collection of 65 human stem cell lines genetically engineered to harbor high risk or causal variants in genes associated with PD (SNCA A53T, SNCA A30P, PRKN Ex3del, PINK1 Q129X, DJ1/PARK7 Ex1-5del, LRRK2 G2019S, ATP13A2 FS, FBXO7 R498X/FS, DNAJC6 c.801 A>G/FS, SYNJ1 R258Q/FS, VPS13C A444P/FS, VPS13C W395C/FS, GBA1 IVS2+1/FS). All mutations were introduced into a fully characterized and sequenced female human embryonic stem cell (hESC) line (WIBR3; NIH approval number NIHhESC-10-0079) using different genome editing techniques. To ensure the genetic integrity of these cell lines, we implemented rigorous quality controls, including whole-genome sequencing of each line. Our analysis of the genetic variation in this cell line collection revealed that while genome editing, particularly using CRISPR/Cas9, can introduce rare off-target mutations, the predominant source of genetic variants arises from routine cell culture and are fixed in cell lines during clonal isolation. The observed genetic variation was minimal compared to that typically found in patient-derived iPSC experiments and predominantly affected non-coding regions of the genome. Importantly, our analysis outlines strategies for effectively managing genetic variation through stringent quality control measures and careful experimental design. This systematic approach ensures the high quality of our stem cell collection, highlights advantages of prime editing over conventional CRISPR/Cas9 methods and provides a roadmap for the generation of gene-edited hPSC collections at scale in an academic setting. Our iSCORE-PD collection represents an easily accessible and valuable platform to study PD, which can be used by investigators to understand the molecular pathophysiology of PD in a human cellular setting.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protein aggregation and calcium dysregulation are the earliest hallmarks of synucleinopathy in human midbrain dopaminergic neurons 95%
- Early striatal hyperexcitability in an in vitro human striatal microcircuit model carrying the Parkinson's GBA-N370S mutation 95%
- Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease 94%
Similar papers in this journal
- Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia 96%
- CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro 96%
- Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease 95%
Similar papers in this journal
- Injectable 3D microcultures enable intracerebral transplantation of mature neurons directly reprogrammed from patient fibroblasts 95%
- Chronic exposure to glucocorticoids amplifies inhibitory neuron cell fate during human neurodevelopment in organoids 95%
- Selective Translation Orchestrates Key Signaling Pathways in Primed Pluripotency 94%
Similar papers in this journal
- Directed Differentiation of Human Pluripotent Stem Cells into Radial Glia and Astrocytes Bypasses Neurogenesis 94%
- High resolution multi-scale profiling of embryonic germ cell-like cells derivation reveals pluripotent state transitions in humans 94%
- Leveraging CRISPR activation for rapid assessment of gene editing products in human pluripotent stem cells 93%
Similar papers in this journal
- Maintenance of neuronal TDP-43 expression requires axonal lysosome transport 96%
- Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson's disease 96%
- Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.